Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

5-Amino-1MQ Peptide Cost in 2026: Pricing Breakdown

How Much Does 5-Amino-1MQ Cost in 2026? Pricing Breakdown Key Takeaways 5-Amino-1MQ is not FDA-approved and is available only for research purposes, affecting its legal availability and cost structure. Typical costs for 5-Amino-1MQ can vary widely due to its s

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

How Much Does 5-Amino-1MQ Cost in 2026? Pricing Breakdown

Key Takeaways

5-Amino-1MQ is not FDA-approved and is available only for research purposes, affecting its legal availability and cost structure.

Typical costs for 5-Amino-1MQ can vary widely due to its status, often requiring out-of-pocket payment.

Insurance coverage is generally not applicable for 5-Amino-1MQ due to its non-approval status.

Cost-saving strategies include exploring compounding pharmacies and patient assistance programs.

Comparing costs with alternative therapies can provide context for budgeting decisions.

What Is 5-Amino-1MQ?

5-Amino-1MQ is a small-molecule compound primarily used in research settings to investigate its effects on cellular metabolism, aging, and epigenetic mechanisms. It functions as a selective nicotinamide N-methyltransferase (NNMT) inhibitor, enhancing NAD⁺ salvage pathway flux. For more detailed information, visit the full profile.

Typical Cost Ranges

As 5-Amino-1MQ is not FDA-approved and available only for research purposes, it is not legally available for therapeutic use in the United States. Consequently, specific cost information for therapeutic use is not applicable. In research contexts, costs can vary based on supplier, purity, and quantity, often ranging from $100 to $500 per gram.

Insurance Coverage

Due to its status as a research-only compound, 5-Amino-1MQ is not covered by insurance providers. Generally, insurance coverage is reserved for FDA-approved medications. Patients interested in similar therapies may need to explore out-of-pocket payment options or consider alternative treatments that have insurance backing.

HSA/FSA Eligibility

Given that 5-Amino-1MQ is not approved for therapeutic use, it does not qualify for Health Savings Account (HSA) or Flexible Spending Account (FSA) spending. Patients should consult with their HSA/FSA administrators to verify eligibility for any related expenses.

Telehealth vs. In-Person Pricing

For peptides that are approved for therapeutic use, telehealth clinics often bundle medication and consultation into monthly programs, which can offer cost savings. However, this model is not applicable to 5-Amino-1MQ due to its research-only status.

Ways to Reduce Cost

While direct cost reduction strategies for 5-Amino-1MQ are limited due to its legal status, individuals involved in research may explore the following options:

Compounding Pharmacies: If legal and applicable, compounding pharmacies might offer customized formulations at potentially lower costs.

Patient Assistance Programs: Although rare for research compounds, some manufacturers may offer discounts for bulk purchases.

Discount Tools: Platforms like GoodRx may provide discounts on related compounds, though not specifically for 5-Amino-1MQ.

Cost Compared to Alternatives

When considering alternatives, peptides such as semaglutide, used for metabolic regulation, may offer FDA-approved options with clearer cost structures. These alternatives often have established insurance coverage and documented therapeutic benefits.

What to Ask Your Provider About Cost

What are the legal implications of using 5-Amino-1MQ in a research context?

Are there alternative therapies with similar mechanisms that are FDA-approved?

What are the potential out-of-pocket costs for comparable treatments?

FAQ

Is 5-Amino-1MQ covered by insurance?

No, 5-Amino-1MQ is not covered by insurance as it is not FDA-approved and is intended for research purposes only.

Can I use HSA/FSA funds for 5-Amino-1MQ?

No, 5-Amino-1MQ does not qualify for HSA/FSA spending due to its non-therapeutic status.

Are there any legal ways to reduce the cost of 5-Amino-1MQ?

Cost reduction is challenging due to its research-only status, but exploring compounding pharmacies and potential bulk discounts might help.

How does the cost of 5-Amino-1MQ compare to other peptides?

Compared to FDA-approved peptides, 5-Amino-1MQ lacks insurance coverage and established therapeutic use, impacting its cost structure.

What should I discuss with my provider regarding the cost of peptide therapy?

Discuss legal implications, potential alternatives, and any available cost-saving programs for similar approved therapies.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any treatment.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

comparison

Comparison to other compound dosing

For context, the dosing requirements of 5-amino-1mq differ significantly from traditional peptides. Where compounds like BPC-157 or TB-500 are dosed in micrograms, 5-amino-1mq is dosed in m…

Source: seekpeptides.com
comparison

NNMT Inhibitor 5-Amino-1MQ Versus Peptide Therapy Options

5-Amino-1MQ targets NNMT and is a small molecule. GLP-1 or GIP/GLP-1 metabolic drugs work through incretin hormone receptors and have regulator-reviewed indications when used as approved pr…

Source: peptidedosages.com
Research context

Read sources and limitations before applying a claim.

Researchers Cited in This Article

The researchers below authored or co-authored publications cited in this article. Listing them here identifies sources; it does not mean they wrote, independently reviewed, sponsored, or endorsed this PeptideDosages.com article. The site author is identified in the article byline.

Source: peptidedosages.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

Potential benefits

5-Amino-1MQ Peptide: Benefits, Dosage & Safety (2026)

5-Amino-1MQ Peptide: Benefits, Dosage & Safety (2026) 5-Amino-1MQ is a small-molecule NNMT inhibitor studied for fat loss and NAD+, not a true peptide. A research guide to its benefits, dosage, and side effects. The compound sold as the 5-Amino-1MQ peptide is a synthetic small molecule that blocks an enzyme called NNMT, and early research ties that action to faster fat loss and higher cellular NAD+. It sells under the "peptide" label almost everywhere, yet it is not one. There are no amino acids in it and no peptide bonds. This guide walks through what the molecule is, how it works, what the studies found, how it gets dosed in research, and where the safety picture still has holes. One frame before the details. Almost all of the evidence comes from cells and mice. Read every benefit below as "studied in the lab," not "proven in people." What is 5-Amino-1MQ? 5-Amino-1MQ is a small-molecule inhibitor of nicotinamide N-methyltransferase, an enzyme almost always shortened to NNMT. Its full chemical name is 5-amino-1-methylquinolinium, it carries the CAS number 685079-15-6, and it weighs roughly 159 daltons. That is tiny. A research peptide like BPC-157 weighs about 1,419 daltons and is built from 15 amino acids; this compound is a single ring system with none. Suppliers sell the reference standard as an iodide salt, and the literature describes it as a selective NNMT inhibitor with an IC50 near 1.2 micromolar, meaning it shuts the enzyme down at low concentrations without hittin…

Source: peptidemind.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →